Template:Hypertrophic cardiomyopathy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 227: | Line 227: | ||
:[[Hypertrophic cardiomyopathy medical treatment#Pharmacotherapy|Pharmacotherapy]] | :[[Hypertrophic cardiomyopathy medical treatment#Pharmacotherapy|Pharmacotherapy]] | ||
:[[Hypertrophic cardiomyopathy medical treatment#2011 ACCF/AHA Guideline Recommendations: Pharmacologic Management in Symptomatic Patients|Guidelines]] | :[[Hypertrophic cardiomyopathy medical treatment#2011 ACCF/AHA Guideline Recommendations: Pharmacologic Management in Symptomatic Patients|Guidelines]] | ||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Hypertrophic cardiomyopathy interventions|Interventions]] | |||
|- | |- | ||
! | ! |
Revision as of 19:13, 18 November 2019
Hypertrophic Cardiomyopathy Microchapters |
Pathophysiology |
---|
Differentiating Hypertrophic Cardiomyopathy from other Diseases |
Diagnosis |
Treatment |
Medical Therapy |
Invasive Therapy |
Special Scenario |
Hypertrophic cardiomyopathy On the Web |
Directions to Hospitals Treating Hypertrophic cardiomyopathy |
Risk calculators and risk factors for Hypertrophic cardiomyopathy |